Giredestrant

Roche’s oral SERD giredestrant fails breast cancer trial
Pharmaforum
Mon, 04/25/22 - 10:48 am
Roche
breast cancer
SERD
Giredestrant
clinical trials
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Roche
tiragolumab
Giredestrant
Sanofi
Eli Lilly
tirzepatide
Novo Nordisk
GSK
Pfizer
RSV
ESMO21: Roche’s giredestrant takes stage in battle of the oral SERDs
Pharmaforum
Fri, 09/17/21 - 11:36 am
Roche
Giredestrant
Serds
breast cancer
ESMO
AstraZeneca
Faslodex
Validation for a drug class, and for Sanofi
EP Vantage
Wed, 05/12/21 - 10:44 am
Sanofi
Serds
breast cancer
Amcenestrant
Radius Health
Elacestrant
Roche
Giredestrant
AstraZeneca
Camizestrant